List of Excipients in Branded Drug METOCLOPRAMIDE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
ANI Pharmaceuticals Inc	METOCLOPRAMIDE	metoclopramide	62559-295	ALUMINUM OXIDE
ANI Pharmaceuticals Inc	METOCLOPRAMIDE	metoclopramide	62559-295	ANHYDROUS LACTOSE
ANI Pharmaceuticals Inc	METOCLOPRAMIDE	metoclopramide	62559-295	CELLULOSE, MICROCRYSTALLINE
ANI Pharmaceuticals Inc	METOCLOPRAMIDE	metoclopramide	62559-295	D&C YELLOW NO. 10

Generic Drugs Containing METOCLOPRAMIDE

Company	Ingredient	NDC	Excipient
Teva Pharmaceuticals USA, Inc.	metoclopramide	0093-2204	ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Teva Pharmaceuticals USA, Inc.	metoclopramide	0093-2204	CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA, Inc.	metoclopramide	0093-2204	MAGNESIUM STEARATE
Teva Pharmaceuticals USA, Inc.	metoclopramide	0093-2204	SODIUM STARCH GLYCOLATE TYPE A POTATO

What are the Most Frequently-Used Excipients in METOCLOPRAMIDE?

# Of NDCs	Excipient
10	ANHYDROUS CITRIC ACID
20	ANHYDROUS DIBASIC CALCIUM PHOSPHATE
2	ANHYDROUS LACTOSE
10	CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient Strategy and Commercial Opportunities for Metoclopramide

Last updated: February 26, 2026

What is the Role of Excipients in Metoclopramide Formulations?

Excipients in metoclopramide formulations perform functions including stability enhancement, bioavailability improvement, and patient compliance. Common excipients include:

• Binders: Microcrystalline cellulose
• Fillers: Lactose monohydrate
• Disintegrants: Crosscarmellose sodium
• Lubricants: Magnesium stearate
• Coatings: Hydroxypropyl methylcellulose (HPMC)

These excipients influence the pharmacokinetics, storage stability, and ease of administration. For generic versions, excipient composition must meet regulatory standards, often matching branded products to preserve bioequivalence [1].

How Do Excipient Choices Impact Formulation Development?

Selection of excipients directly affects:

• Bioavailability: Certain excipients, like sodium starch glycolate, facilitate disintegration and dissolution, critical for oral tablets.
• Stability: Surfactants or antioxidants prevent drug degradation.
• Patient tolerability: Flavoring agents or masking agents reduce gastrointestinal irritation.

In liquid formulations, preservatives such as methylparaben ensure microbial stability, whereas in injectables, excipients like sodium chloride maintain isotonicity.

What Are Current Market Trends in Excipient Use for Metoclopramide?

Increasing interest in patient-centric formulations leads to:

• Development of orodispersible tablets utilizing superdisintegrants
• Use of biodegradable coatings to improve swallowing
• Incorporation of non-allergenic fillers to reduce adverse reactions

Regulatory agencies emphasize excipient safety profiles. Industry trends favor excipients with well-documented toxicology and compatibility with new delivery routes.

Where Are Commercial Opportunities for Excipient Innovation?

Potential areas include:

• Enhanced bioavailability excipients: Novel disintegrants or permeation enhancers.
• Patient-friendly formulations: Orally disintegrating tablets or pre-measured sachets with optimized excipient blends.
• Biodegradable coatings or matrix systems: To achieve controlled release and reduce dosing frequency.

Market analysts project a compound annual growth rate (CAGR) of 4% for excipient segments tied to gastrointestinal drugs from 2022 to 2030 [2].

How Does Excipient Strategy Influence Market Competition?

Manufacturers employing unique excipient compositions gain regulatory and marketing advantages, such as:

• Differentiation through improved stability and bioavailability
• Extension of patent protection via formulation patents
• Entry into emerging markets demanding specific excipient specifications

Customization of excipient profiles enables probiotic, pediatric, or geriatric formulations, expanding market access.

Key Regulatory Considerations

• Compliance with FDA's Inactive Ingredient Database
• Labeling requirements for allergenic excipients
• Documentation of excipient safety and compatibility data for new formulations

Regulatory pathways for excipient modifications involve abbreviated new drug applications (ANDAs) for generics, with bioequivalence testing focused on formulation excipient similarities.

Summary Table: Typical Excipients in Metoclopramide Tablets

Function	Common Excipients	Regulatory Notes
Binder	Microcrystalline cellulose	Must be pharmaceutically graded
Disintegrant	Crosscarmellose sodium	Approved for oral use
Lubricant	Magnesium stearate	Required in minimal quantities
Filler	Lactose monohydrate	Allergies require alternatives

Market Data

• The global pharmaceutical excipients market was valued at USD 7.4 billion in 2021.
• Expected CAGR of 6.4% from 2022 to 2030 [2].
• Key growth drivers include product innovation, formulations for biosimilars, and targeted delivery systems.

Competitive Landscape

Major players include:

• FMC BioPolymer
• Dow
• Meggle AG
• Roquette
• Evonik Industries

Innovation focuses on excipients supporting sustained-release formulations and alternative delivery routes such as nasal or injectable systems.

Conclusions

• Excipient selection critically influences metoclopramide formulation efficacy, stability, and patient adherence.
• Innovation opportunities arise around bioavailability, patient comfort, and controlled-release delivery.
• Strategic excipient choices can extend patent life and provide competitive differentiation.

---

Key Takeaways

• Excipients in metoclopramide formulations impact bioavailability, stability, and tolerability; choices influence product success.
• Growth in alternative delivery methods fosters innovation in excipient design, including disintegrants and coatings.
• Regulatory and safety considerations shape excipient selection, especially for emerging markets.
• Market trends favor biodegradable, patient-friendly excipient systems, with a projected CAGR of 6.4% for excipient segments until 2030.
• Large players lead innovation, but regional regulations and formulation patents influence competitive dynamics.

---

FAQs

1. What excipients are standard in metoclopramide tablets?
Microcrystalline cellulose (binder), crosscarmellose sodium (disintegrant), magnesium stearate (lubricant), lactose monohydrate (filler), and hydroxypropyl methylcellulose (coating).

2. How does excipient choice affect metoclopramide bioavailability?
Excipients like superdisintegrants enhance tablet breakup, increasing drug dissolution and absorption.

3. Are there excipient safety concerns with metoclopramide formulations?
Yes. Excipients must comply with FDA safety standards, avoiding allergens like lactose if prescribed for sensitive populations.

4. What innovation trends are shaping excipient development in this segment?
Development of orodispersible tablets, biodegradable coatings, and bioenhancers.

5. How do excipient patents influence market exclusivity?
Formulation patents on unique excipient combinations can extend exclusivity beyond patent life, offering competitive advantages.

---

References

[1] U.S. Food and Drug Administration. (2022). Inactive Ingredient Database.
[2] MarketsandMarkets. (2022). Pharmaceutical Excipients Market Report.